Human dermal fibroblast‐derived extracellular matrix reduces postinflammatory hyperpigmentation after fractional carbon dioxide laser facial resurfacing in Asians
Journal of Cosmetic Dermatology · 2023
DOI: 10.1111/jocd.15713 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2023. Verfasst von Sang-Min Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Graduate School, Kyung Hee University, Seoul, South Korea. Hauptthemen laut MEDLINE: Extracellular Matrix, Hyperpigmentation, Laser Therapy, Lasers, Gas. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amorepacific Corporation.
Abstract (Originalsprache)
Background
Extracellular matrix (ECM) components promote the development of skin wounds by providing biological scaffolds and regenerative microenvironments.
Aims
To evaluate the beneficial effects of human dermal fibroblast‐derived ECM after fractional carbon dioxide laser resurfacing in Asians. Patients/Methods In this double‐blind, randomized, vehicle‐controlled, split‐face study, 15 participants with features of facial skin aging were treated with a single session of fractional carbon dioxide laser, followed by the application of either ECM (ECM group) or placebo (control group). In vivo skin parameters were measured at baseline and after 4 and 12 weeks of treatment using the Antera 3D®, Cutometer® MPA580, Dermascan®, and Tewameter®.
Results
A total of 14 participants (mean age 45.1 ± 9.7 years) completed the study. The change in melanin level was significantly lower in the ECM group than in the control group at week 12 ( p < 0.05). Transient increase in erythema level was observed at week 4 in the control group, and the change in the erythema level was greater in the control group than in the ECM group ( p = 0.014). Though the ECM group showed improvements in the dermal density, texture, transepidermal water loss, marionette lines (volume, maximum depth, and average depth), and nasolabial folds (volume, maximum depth, and length), no significant differences were found between the two groups. Treatment‐related adverse events were not reported.
Conclusions
We suggest that human dermal fibroblast‐derived ECM may be used as adjunctive therapy after fractional carbon dioxide resurfacing to prevent postinflammatory hyperpigmentation in Asians.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Graduate School, Kyung Hee University, Seoul, South Korea.
- IDEA Plastic Surgery, Seoul, South Korea.
- Department of Plastic Surgery, Kyung Hee University Hospital, Seoul, South Korea.
- Department of Dermatology, Kyung Hee University Hospital at Gang-dong, Kyung Hee University School of Medicine, Seoul, South Korea.
ORCID-Profile: Bark-Lynn Lew, Soon-Hyo Kwon
Förderung
- Amorepacific Corporation
Zitieren
APA
Choi, S. M., Kook, K. S., Park, J., Lew, B. L., & Kwon, S. H. (2023). Human dermal fibroblast‐derived extracellular matrix reduces postinflammatory hyperpigmentation after fractional carbon dioxide laser facial resurfacing in Asians. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15713
Vancouver
Choi SM, Kook KS, Park J, Lew BL, Kwon SH. Human dermal fibroblast‐derived extracellular matrix reduces postinflammatory hyperpigmentation after fractional carbon dioxide laser facial resurfacing in Asians. Journal of Cosmetic Dermatology. 2023. doi:10.1111/jocd.15713
BibTeX
@article{Choi2023,
author = {Choi, Sang-Min and Kook, Kwang-Sik and Park, Jun and Lew, Bark-Lynn and Kwon, Soon-Hyo},
title = {Human dermal fibroblast‐derived extracellular matrix reduces postinflammatory hyperpigmentation after fractional carbon dioxide laser facial resurfacing in Asians},
journal = {Journal of Cosmetic Dermatology},
year = {2023},
doi = {10.1111/jocd.15713}
}
EUVIMED